Other Assets (Tables)

3 Months Ended

Mar. 31, 2026

The following table presents the components of other assets as of the dates indicated:


(In millions)	March 31, 2026		December 31, 2025
Securities borrowed(1)	$	47,989	$	38,233
Derivative instruments, net	8,491		4,155
Receivable for securities settlement	4,665		102
Bank-owned life insurance	3,997		3,965
Investments in joint ventures and other unconsolidated entities(2)	3,879		3,753
Collateral, net	2,694		1,603
Prepaid expenses	961		837
Right-of-use assets	833		865
Accounts receivable	789		621
Deferred tax assets, net of valuation allowance(3)	608		627







Income taxes receivable	258		256


Other(4)	3,467		3,451
Total	$	78,631	$	58,468

(1) Refer to Note 8, for further information on the impact of collateral on our financial statement presentation of securities borrowing and securities lending transactions.

(2) Includes equity securities without readily determinable fair values that are accounted for under the ASC 321 measurement alternative of $586 million and $585 million as of March 31, 2026 and December 31, 2025, respectively. For the three months ended March 31, 2026, no impairments were recognized in other fee revenue related to such equity securities.

(3) Deferred tax assets and liabilities recorded in our consolidated statement of condition are netted within the same tax jurisdiction.

(4) Includes advances of $1.50 billion and capitalized costs to fulfill contracts with customers of $1.22 billion, as of March 31, 2026, compared to $1.57 billion and $1.19 billion, respectively, as of December 31, 2025.